| Literature DB >> 24582632 |
Ian G Barr1, Colin Russell2, Terry G Besselaar3, Nancy J Cox4, Rod S Daniels5, Ruben Donis4, Othmar G Engelhardt6, Gary Grohmann7, Shigeyuki Itamura8, Anne Kelso9, John McCauley5, Takato Odagiri8, Stacey Schultz-Cherry10, Yuelong Shu11, Derek Smith12, Masato Tashiro8, Dayan Wang11, Richard Webby10, Xiyan Xu4, Zhiping Ye13, Wenqing Zhang3.
Abstract
In February the World Health Organisation (WHO) recommends influenza viruses to be included in influenza vaccines for the forthcoming winter in the Northern Hemisphere. These recommendations are based on data collected by National Influenza Centres (NICs) through the WHO Global Influenza Surveillance and Response System (GISRS) and a more detailed analysis of representative and potential antigenically variant influenza viruses from the WHO Collaborating Centres for Influenza (WHO CCs) and Essential Regulatory Laboratories (ERLs). This article provides a detailed summary of the antigenic and genetic properties of viruses and additional background data used by WHO experts during development of the recommendations of the 2013-2014 Northern Hemisphere influenza vaccine composition. Published by Elsevier Ltd.Entities:
Keywords: 2013–2014; Human; Influenza; Northern Hemisphere; Quadrivalent; Recommendation; Trivalent; Vaccine
Mesh：
Substances：
Year: 2014 PMID： 24582632 DOI： 10.1016/j.vaccine.2014.02.014
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641